Literature DB >> 25861597

Isoproterenol infusion in septic shock.

Viroj Wiwanitkit1.   

Abstract

Entities:  

Year:  2015        PMID: 25861597      PMCID: PMC4381829     

Source DB:  PubMed          Journal:  Heart Lung Vessel        ISSN: 2282-8419


× No keyword cloud information.

Dear Editor, the recent report on “Isoproterenol infusion in septic shock” is very interesting [1]. Wiramus et al. concluded that “use of isoproterenol was associated with an increase of tissue oxygen saturation [1].” In fact, there are some issues of isoproterenol use to be discussed. First, the increased heart rate due to infusion is common [2]. On the other hand, the occurrence of paradoxical bradycardia can also be observed [3]. In addition, the possibility of occurrence of isoproterenol-induced myocardial infarction should be kept in mind [4]. The fatal case due to the infusion is reported in the literature [5]. To prevent cardiac toxicity due to isoproterenol infusion, careful evaluation before usage is required.
  5 in total

Review 1.  Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models.

Authors:  Monika Garg; Deepa Khanna
Journal:  Ther Adv Cardiovasc Dis       Date:  2014-05-09

2.  Paradoxical effect of isoprenaline infusion.

Authors:  Béatrice Brembilla-Perrot; Ihad Muhanna; Marc Nippert; Batric Popovic; Daniel Beurrier; Pierre Houriez; Arnaud Terrier de la Chaise; Olivier Claudon; Pierre Louis; Ahmed Abdelaal; Simona State; Marius Andronache; Christine Suty-Selton
Journal:  Europace       Date:  2005-09-22       Impact factor: 5.214

3.  Isoproterenol infusion and microcirculation in septic shock.

Authors:  S Wiramus; J Textoris; R Bardin; C Vigne; C Kelway; C Martin; M Leone
Journal:  Heart Lung Vessel       Date:  2014

4.  A reappraisal of isoproterenol in goal-directed therapy of septic shock.

Authors:  Marc Leone; Ioanna Boyadjiev; Emile Boulos; Francois Antonini; Pierre Visintini; Jacques Albanèse; Claude Martin
Journal:  Shock       Date:  2006-10       Impact factor: 3.454

5.  Fatal myocardial toxicity during continuous infusion intravenous isoproterenol therapy of asthma.

Authors:  G Kurland; J Williams; N J Lewiston
Journal:  J Allergy Clin Immunol       Date:  1979-06       Impact factor: 10.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.